ET Healthcare vs Saluda Medical
Side-by-side comparison of AI visibility scores, market position, and capabilities
Isotachophoresis-Based Sample Preparation for Diagnostics & Research
ET Healthcare develops isotachophoresis (ITP) technology for rapid, automated nucleic acid and biomarker sample preparation in life sciences research and diagnostics; enables faster processing with minimal sample volumes;
About
ET Healthcare is a Menlo Park, California-based life sciences instrumentation company that develops sample preparation technology based on isotachophoresis (ITP) — an electrokinetic technique that concentrates and purifies nucleic acids, proteins, and other biomolecules from complex biological samples without centrifugation or column-based purification steps. ITP uses electric fields to focus and separate analytes by their electrophoretic mobility, enabling very rapid (often sub-10-minute) purification from small sample volumes with minimal hands-on steps.
Saluda Medical is the pioneer of closed-loop spinal cord stimulation (SCS); FDA-approved Evoke SCS system with real-time neural feedback; raised $100M in Jan 2025; received FDA clearance for automated EVA programming platform.
About
Saluda Medical is a commercial-stage medical device company that has pioneered closed-loop neuromodulation therapy for chronic pain management. Headquartered in Macquarie Park, Australia (with US operations in Marlborough, Massachusetts), Saluda''s flagship product is the Evoke Spinal Cord Stimulation (SCS) System — the world''s first SCS system that senses and measures neural responses to stimulation (evoked compound action potentials, or ECAPs) and automatically adjusts therapy in real time based on each patient''s neurophysiological feedback. This closed-loop approach provides more precise, consistent pain relief compared to conventional open-loop SCS systems.
AI Visibility Head-to-Head
Key Details
Also Compare
ET Healthcare vs
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.